Here's the live share price of Anthem Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Anthem Biosciences has declined 1.95% CAGR. Over the past year, the corresponding return has been -9.36%.
Anthem Biosciences’s current P/E of 72.03x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Anthem Biosciences | 4.24 | -4.95 | -20.22 | -9.36 | -9.36 | -3.22 | -1.95 |
| Sun Pharmaceutical Industries | -0.69 | 7.88 | 14.04 | 8.04 | 0.49 | 20.57 | 26.17 |
| Divi's Laboratories | -0.94 | -6.8 | 6.8 | -3.2 | 5.29 | 23.98 | 11.58 |
| Torrent Pharmaceuticals | 2.19 | 7 | 6.24 | 20.97 | 13.09 | 32.96 | 23.34 |
| Cipla | -0.64 | 1.41 | -2.07 | 2.12 | 1.49 | 10.89 | 14.69 |
| Dr. Reddy's Laboratories | 1.7 | 6.18 | 0.86 | -0.81 | 3.17 | 12.62 | 5.45 |
| Lupin | 0.53 | 6.95 | 7.57 | 4.84 | -1.58 | 39.53 | 17.53 |
| Zydus Lifesciences | -0.73 | -0.09 | -7.77 | -2.11 | -4.38 | 31.31 | 14.71 |
| Mankind Pharma | -1.8 | -4.24 | -13.33 | -6.35 | -15.57 | 15.8 | 9.2 |
| Aurobindo Pharma | -0.02 | 7.29 | 17.16 | 5.53 | -1.61 | 37.96 | 6.33 |
| Alkem Laboratories | -3.11 | -2.4 | 3.21 | 13.79 | -2.44 | 20.9 | 14.04 |
| Abbott India | -4.13 | -2.21 | -7.54 | -9.06 | -0.68 | 12.85 | 13.59 |
| Glenmark Pharmaceuticals | 1.53 | 9.18 | -3.73 | 24.72 | 27.98 | 65.57 | 31.47 |
| Laurus Labs | -1.89 | 3.37 | 14.85 | 57.95 | 72.05 | 34 | 24.99 |
| Biocon | -2.5 | 0.84 | 6.72 | 17.42 | 3.56 | 11.64 | -2.59 |
| GlaxoSmithKline Pharmaceuticals | -2.49 | -3.84 | -9.66 | -27.66 | 5.29 | 23.15 | 10.02 |
| Ipca Laboratories | 0.26 | 11.87 | 9.12 | 5.06 | -2.54 | 19.06 | 5.31 |
| Ajanta Pharma | 2.5 | 2.01 | 0.28 | 1.73 | -10.14 | 27.56 | 19.78 |
| J B Chemicals & Pharmaceuticals | 3.28 | 8.07 | 6.4 | 7.74 | 2.71 | 21.9 | 29.77 |
| Gland Pharma | -1.85 | -9.04 | -8.8 | 5.93 | -5.77 | -0.45 | -4.53 |
Over the last one year, Anthem Biosciences has declined 9.36% compared to peers like Sun Pharmaceutical Industries (0.49%), Divi's Laboratories (5.29%), Torrent Pharmaceuticals (13.09%). From a 5 year perspective, Anthem Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (26.17%) and Divi's Laboratories (11.58%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 647.37 | 654.92 |
| 10 | 641.79 | 652.72 |
| 20 | 661.41 | 664.05 |
| 50 | 720.09 | 702.91 |
| 100 | 702.08 | 0 |
| 200 | 351.04 | 0 |
In the latest quarter, Anthem Biosciences remained same as its previous close in promoter holding, while DII stake increased to 7.21%, FII holding rose to 1.66%, and public shareholding moved down to 16.42% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 36,82,926 | 0.86 | 261.52 | |
| 24,96,297 | 0.98 | 177.26 | |
| 21,11,545 | 1.21 | 149.94 | |
| 16,83,389 | 1.4 | 119.54 | |
| 16,00,000 | 1.91 | 113.62 | |
| 14,40,566 | 0.29 | 102.29 | |
| 13,35,040 | 3.19 | 94.8 | |
| 12,00,000 | 2.09 | 85.21 | |
| 11,07,065 | 1.88 | 78.61 | |
| 10,58,503 | 0.9 | 75.16 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 12, 2025, 11:49 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 11, 2025, 5:51 AM IST | Anthem Biosciences - Intimation Of Violation Under Company'S Code Of Conduct To Regulate, Monitor And Report Trading By Desig |
| Nov 10, 2025, 10:18 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 09, 2025, 2:33 AM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 09, 2025, 2:32 AM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Investor Presentation |
Anthem Biosciences Ltd. is a Public Limited Listed company incorporated on 13/06/2006 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is U24233KA2006PLC039703 and registration number is 039703. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1840.65 Cr. and Equity Capital is Rs. 111.82 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Anthem Biosciences is ₹662.00 as on Dec 04, 2025.
The Anthem Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Anthem Biosciences is ₹37,178.59 Cr as on Dec 04, 2025.
Today’s highest and lowest price of Anthem Biosciences are ₹664.00 and ₹657.00.
The 52-week high/low is the highest and lowest price at which Anthem Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Anthem Biosciences is ₹873.50 and 52-week low of Anthem Biosciences is ₹620.00 as on Dec 04, 2025.
The Anthem Biosciences has shown returns of -0.11% over the past day, -5.77% for the past month, -21.56% over 3 months, -9.36% over 1 year, -3.22% across 3 years, and -1.95% over 5 years.
P/E ratio of and PB ratio of Anthem Biosciences are 72.03 and 15.42 on Dec 04, 2025. While the company gives a dividend yield of 0.00 per annum.